EP1901757A2 - Preparations made from natural materials - Google Patents
Preparations made from natural materialsInfo
- Publication number
- EP1901757A2 EP1901757A2 EP06792472A EP06792472A EP1901757A2 EP 1901757 A2 EP1901757 A2 EP 1901757A2 EP 06792472 A EP06792472 A EP 06792472A EP 06792472 A EP06792472 A EP 06792472A EP 1901757 A2 EP1901757 A2 EP 1901757A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- extracts
- biomass
- ganoderma
- preparation
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000002360 preparation method Methods 0.000 title claims description 74
- 239000000463 material Substances 0.000 title abstract description 3
- 239000000284 extract Substances 0.000 claims abstract description 86
- 239000000203 mixture Substances 0.000 claims abstract description 83
- 241000222336 Ganoderma Species 0.000 claims abstract description 50
- 241000233866 Fungi Species 0.000 claims abstract description 39
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 35
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 32
- 239000011707 mineral Substances 0.000 claims abstract description 32
- 230000003712 anti-aging effect Effects 0.000 claims abstract description 19
- 229920001222 biopolymer Polymers 0.000 claims abstract description 15
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 14
- 230000002538 fungal effect Effects 0.000 claims abstract description 14
- 229910052742 iron Inorganic materials 0.000 claims abstract description 12
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000015872 dietary supplement Nutrition 0.000 claims abstract description 7
- 230000004224 protection Effects 0.000 claims abstract description 7
- 239000003814 drug Substances 0.000 claims abstract description 6
- 239000002028 Biomass Substances 0.000 claims description 52
- 241001480610 Ganoderma pfeifferi Species 0.000 claims description 44
- 238000000034 method Methods 0.000 claims description 38
- 240000008397 Ganoderma lucidum Species 0.000 claims description 37
- 229910052615 phyllosilicate Inorganic materials 0.000 claims description 32
- 239000002105 nanoparticle Substances 0.000 claims description 22
- 230000000694 effects Effects 0.000 claims description 18
- 239000011859 microparticle Substances 0.000 claims description 17
- 239000004927 clay Substances 0.000 claims description 15
- 239000002994 raw material Substances 0.000 claims description 14
- 239000000469 ethanolic extract Substances 0.000 claims description 13
- 239000002537 cosmetic Substances 0.000 claims description 12
- 241000894007 species Species 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 10
- 230000029087 digestion Effects 0.000 claims description 9
- 230000006750 UV protection Effects 0.000 claims description 8
- 239000004480 active ingredient Substances 0.000 claims description 8
- 230000015572 biosynthetic process Effects 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- 238000011282 treatment Methods 0.000 claims description 8
- 230000008859 change Effects 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 210000002421 cell wall Anatomy 0.000 claims description 6
- 230000004936 stimulating effect Effects 0.000 claims description 6
- 239000006286 aqueous extract Substances 0.000 claims description 5
- 230000000475 sunscreen effect Effects 0.000 claims description 5
- 239000000516 sunscreening agent Substances 0.000 claims description 5
- 241000196324 Embryophyta Species 0.000 claims description 4
- 235000006468 Thea sinensis Nutrition 0.000 claims description 4
- 239000000654 additive Substances 0.000 claims description 4
- 230000000845 anti-microbial effect Effects 0.000 claims description 4
- 238000011321 prophylaxis Methods 0.000 claims description 4
- 241001480612 Ganoderma resinaceum Species 0.000 claims description 3
- 206010028980 Neoplasm Diseases 0.000 claims description 3
- 239000003921 oil Substances 0.000 claims description 3
- 240000000731 Fagus sylvatica Species 0.000 claims description 2
- 235000010099 Fagus sylvatica Nutrition 0.000 claims description 2
- 241001480617 Ganoderma adspersum Species 0.000 claims description 2
- 208000001132 Osteoporosis Diseases 0.000 claims description 2
- 241000222383 Polyporales Species 0.000 claims description 2
- 239000003674 animal food additive Substances 0.000 claims description 2
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 2
- 238000013270 controlled release Methods 0.000 claims description 2
- 239000000077 insect repellent Substances 0.000 claims description 2
- 238000003801 milling Methods 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 239000003883 ointment base Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 238000005728 strengthening Methods 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 239000002023 wood Substances 0.000 claims description 2
- 244000052707 Camellia sinensis Species 0.000 claims 2
- 238000000227 grinding Methods 0.000 claims 2
- 235000013325 dietary fiber Nutrition 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 230000029663 wound healing Effects 0.000 claims 1
- 150000003254 radicals Chemical class 0.000 abstract description 18
- 230000032677 cell aging Effects 0.000 abstract description 6
- 239000004904 UV filter Substances 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 37
- 230000002292 Radical scavenging effect Effects 0.000 description 25
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 25
- 235000010755 mineral Nutrition 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- 239000002245 particle Substances 0.000 description 19
- 230000003078 antioxidant effect Effects 0.000 description 18
- 238000007792 addition Methods 0.000 description 14
- 239000002734 clay mineral Substances 0.000 description 14
- 238000000605 extraction Methods 0.000 description 13
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 235000013305 food Nutrition 0.000 description 11
- 239000004408 titanium dioxide Substances 0.000 description 11
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 10
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 10
- 239000002609 medium Substances 0.000 description 10
- 230000001681 protective effect Effects 0.000 description 10
- 230000005855 radiation Effects 0.000 description 10
- 229910052711 selenium Inorganic materials 0.000 description 10
- 239000011669 selenium Substances 0.000 description 10
- 240000001462 Pleurotus ostreatus Species 0.000 description 9
- 235000001603 Pleurotus ostreatus Nutrition 0.000 description 9
- 230000006378 damage Effects 0.000 description 9
- 230000001699 photocatalysis Effects 0.000 description 9
- 235000012216 bentonite Nutrition 0.000 description 8
- 238000011835 investigation Methods 0.000 description 8
- 229940082787 spirulina Drugs 0.000 description 8
- 240000002900 Arthrospira platensis Species 0.000 description 7
- 235000016425 Arthrospira platensis Nutrition 0.000 description 7
- 239000013543 active substance Substances 0.000 description 7
- 235000012211 aluminium silicate Nutrition 0.000 description 7
- 238000004113 cell culture Methods 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 239000011777 magnesium Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 240000000599 Lentinula edodes Species 0.000 description 6
- 235000001715 Lentinula edodes Nutrition 0.000 description 6
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 229910010413 TiO 2 Inorganic materials 0.000 description 6
- 239000000440 bentonite Substances 0.000 description 6
- 229910000278 bentonite Inorganic materials 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 235000019624 protein content Nutrition 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 239000005995 Aluminium silicate Substances 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 5
- 230000005540 biological transmission Effects 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 239000006052 feed supplement Substances 0.000 description 5
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 5
- 229960005205 prednisolone Drugs 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000002516 radical scavenger Substances 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 235000012239 silicon dioxide Nutrition 0.000 description 5
- 210000004927 skin cell Anatomy 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 5
- 239000010457 zeolite Substances 0.000 description 5
- 229910052725 zinc Inorganic materials 0.000 description 5
- 239000011701 zinc Substances 0.000 description 5
- 244000028550 Auricularia auricula Species 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 239000012979 RPMI medium Substances 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 239000012675 alcoholic extract Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910002091 carbon monoxide Inorganic materials 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 230000004153 glucose metabolism Effects 0.000 description 4
- 229910052901 montmorillonite Inorganic materials 0.000 description 4
- 229910000273 nontronite Inorganic materials 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 239000010453 quartz Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- WCBPJVKVIMMEQC-UHFFFAOYSA-N 1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NN(C=1C=CC=CC=1)C1=CC=CC=C1 WCBPJVKVIMMEQC-UHFFFAOYSA-N 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241000123330 Fomes fomentarius Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000237502 Ostreidae Species 0.000 description 3
- 240000004371 Panax ginseng Species 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 206010063493 Premature ageing Diseases 0.000 description 3
- 208000032038 Premature aging Diseases 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 230000019522 cellular metabolic process Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 230000002906 microbiologic effect Effects 0.000 description 3
- 229960004857 mitomycin Drugs 0.000 description 3
- 239000005445 natural material Substances 0.000 description 3
- 235000020636 oyster Nutrition 0.000 description 3
- 230000002028 premature Effects 0.000 description 3
- 150000004760 silicates Chemical class 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 235000000023 Auricularia auricula Nutrition 0.000 description 2
- 229920002498 Beta-glucan Polymers 0.000 description 2
- 229910021532 Calcite Inorganic materials 0.000 description 2
- 241000195585 Chlamydomonas Species 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 2
- 240000001080 Grifola frondosa Species 0.000 description 2
- 235000007710 Grifola frondosa Nutrition 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 2
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 2
- 235000007685 Pleurotus columbinus Nutrition 0.000 description 2
- 241000206618 Porphyridium Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 238000001354 calcination Methods 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 229910001919 chlorite Inorganic materials 0.000 description 2
- 229910052619 chlorite group Inorganic materials 0.000 description 2
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 description 2
- 239000013065 commercial product Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000001086 cytosolic effect Effects 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 210000005069 ears Anatomy 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 229910052900 illite Inorganic materials 0.000 description 2
- 229940099472 immunoglobulin a Drugs 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- VGIBGUSAECPPNB-UHFFFAOYSA-L nonaaluminum;magnesium;tripotassium;1,3-dioxido-2,4,5-trioxa-1,3-disilabicyclo[1.1.1]pentane;iron(2+);oxygen(2-);fluoride;hydroxide Chemical compound [OH-].[O-2].[O-2].[O-2].[O-2].[O-2].[F-].[Mg+2].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[K+].[K+].[K+].[Fe+2].O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2 VGIBGUSAECPPNB-UHFFFAOYSA-L 0.000 description 2
- 230000035781 nonspecific defense system Effects 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 230000010412 perfusion Effects 0.000 description 2
- 238000013032 photocatalytic reaction Methods 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000011814 protection agent Substances 0.000 description 2
- 239000011028 pyrite Substances 0.000 description 2
- NIFIFKQPDTWWGU-UHFFFAOYSA-N pyrite Chemical compound [Fe+2].[S-][S-] NIFIFKQPDTWWGU-UHFFFAOYSA-N 0.000 description 2
- 229910052683 pyrite Inorganic materials 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229910021647 smectite Inorganic materials 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000037072 sun protection Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000238582 Artemia Species 0.000 description 1
- 241000221377 Auricularia Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 231100000699 Bacterial toxin Toxicity 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 239000012983 Dulbecco’s minimal essential medium Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241001149422 Ganoderma applanatum Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 244000060234 Gmelina philippensis Species 0.000 description 1
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 1
- 240000000588 Hericium erinaceus Species 0.000 description 1
- 235000007328 Hericium erinaceus Nutrition 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001580017 Jana Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010061291 Mineral deficiency Diseases 0.000 description 1
- 240000001307 Myosotis scorpioides Species 0.000 description 1
- 102100026450 POU domain, class 3, transcription factor 4 Human genes 0.000 description 1
- 101710133389 POU domain, class 3, transcription factor 4 Proteins 0.000 description 1
- 240000003444 Paullinia cupana Species 0.000 description 1
- 235000000556 Paullinia cupana Nutrition 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 244000252132 Pleurotus eryngii Species 0.000 description 1
- 235000001681 Pleurotus eryngii Nutrition 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 229910004283 SiO 4 Inorganic materials 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 241000270708 Testudinidae Species 0.000 description 1
- 244000078534 Vaccinium myrtillus Species 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000004887 air purification Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000019730 animal feed additive Nutrition 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000000688 bacterial toxin Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 238000013452 biotechnological production Methods 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000012482 calibration solution Substances 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000003818 cinder Substances 0.000 description 1
- 229910052570 clay Inorganic materials 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000007278 cognition impairment Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000032798 delamination Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000010459 dolomite Substances 0.000 description 1
- 229910000514 dolomite Inorganic materials 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 239000013003 healing agent Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000011019 hematite Substances 0.000 description 1
- 229910052595 hematite Inorganic materials 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 239000010423 industrial mineral Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- LIKBJVNGSGBSGK-UHFFFAOYSA-N iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Fe+3].[Fe+3] LIKBJVNGSGBSGK-UHFFFAOYSA-N 0.000 description 1
- 229910052622 kaolinite Inorganic materials 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- -1 manit Substances 0.000 description 1
- 230000037306 mature skin Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 229940012843 omega-3 fatty acid Drugs 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 229940033080 omega-6 fatty acid Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 238000007146 photocatalysis Methods 0.000 description 1
- 231100000760 phototoxic Toxicity 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000013324 preserved food Nutrition 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical class O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 244000005714 skin microbiome Species 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 239000003030 smectite-group mineral Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000011885 synergistic combination Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- 244000052613 viral pathogen Species 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/015—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9717—Rhodophycota or Rhodophyta [red algae], e.g. Porphyra
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9722—Chlorophycota or Chlorophyta [green algae], e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/20—Ingredients acting on or related to the structure
- A23V2200/25—Nanoparticles, nanostructures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Definitions
- the invention relates to compositions of biomass and / or extracts of at least one terrestrial fungus, preferably a species of the genus Ganoderma on the one hand and at least one layered silicate, an iron-rich raw material, biomass, obtainable from microalgae, fungal biopolymer complexes on the other.
- the compositions prevent premature cell aging and have an anti-aging effect.
- Possible applications include food and feed supplements, plant tonics or drugs that are designed to protect against free radicals. They are also suitable as UV protection agents based on natural substances.
- a water extract or a low alcohol extract of G. lucidum can be used as a cosmetic (WO 01/32192 Al).
- An alcoholic extract of G. lucidum can be used in dermatoses to prevent inflammation (JP 1180889 A).
- G. lucidum In order to enhance the antioxidant effect, it is possible to mix G. lucidum with grapefruit seed extracts (WO 02/11744 Al). It is also possible to enrich G. lucidum during cultivation with selenium (WO 01/05938 Al). Also known are mixtures with the botanical antioxidants green tea extract, anthocyanins from bilberry fruits, ginkgo, guarana root extract (PCT WO 2004/100896 A2).
- Another way to supplement food or feed is taken when free radicals are removed by adsorption from the organism. It uses the microporous structure of certain minerals. For example, zeolite crystals have tiny cavities and channels, which is due to their ability to absorb free radicals. In this case, other harmful substances are removed.
- the mineral clinoptiolite is a component of the product Phytosorb, which is used as a toxin binder for pig and cattle feed.
- the animal feed additive Lucoton-T uses the absorption capacity of chitin and melanin. For a high absorption ability also phyllosilicates are known.
- Phyllosilicates are salts of silicic acid in which the [SiO 4 ] tetrahedra are interlinked in one plane and thus form lattice lattices. Some of the silicon atoms are replaced by magnesium or aluminum. One differentiates one-, two-, three- and four-layered silicates.
- the layered silicates include, for example, kaolonite, talc, clay or mica. Compositions comprising phyllosilicates and biomass terrestrial fungi, in particular the genus Ganoderma, have not been described.
- 1.3- ⁇ -glucans stimulation of the non-specific defense system, increase in the production of immunoglobulin A (IgA)
- IgA immunoglobulin A
- the antioxidant effect of spirulina is important for use as a dietary supplement (JANA 2002).
- JANA 2002 An indication that the antioxidant effect can be synergistically enhanced by combination with extracts of Ganoderma species is not found in the prior art.
- Known is only the combination of hot water extracts of G. lucidum with hot-water extracts of spirulina (JP 2002 24 9437 A).
- Inorganic UV filters are microfine particles of titanium dioxide or zinc oxide, which reflect the incident UV light. They cover the longer-wave UV-A as well as the shorter-wave UV-B range and are mainly used in sunscreens with a very high sun protection factor. Because these pigments are white, they can cause an undesirable whitening effect on the skin at higher concentrations. To prevent this, the pigment particles are reduced to about 200 nanometers - thus they are transparent.
- UV light When exposed to ultraviolet (UV) light, photocatalytic substances such as titanium dioxide (TiO 2 ;) absorb UV radiation to a high degree. In the reaction of titanium dioxide with UV radiation, however, free radicals are formed in the presence of water and oxygen. This photocatalytic effect is used for various commercial applications such as water and air purification and gives surfaces self-cleaning, antimicrobial and anti-algae properties (DE199623055). In the photocatalytic reaction, very reactive free radicals are formed, which form a strong Chem. Res., Vol. 28, No. 12 (1995) 503 / D. Bruemann: Photocatalytic Detoxification of Polluted Waters, The Handbook of Environmental Chemistry, Springer Verlag 1999, Volume 2, Part L, 285 - 351.
- the object of the present invention is to find formulations with improved properties compared to the prior art which stimulate glucose metabolism, protect cells from damage and / or slow cell aging, stabilize the natural intestinal flora and bind toxins and which can therefore be used as food or feed and / or as a food or feed supplement and / or as cosmetics and / or as medicaments for therapeutic and prophylactic applications in humans and / or animals.
- cosmetics in particular, a possibility should be found of combining UV protection and protection against premature skin aging by the residual UV radiation.
- a composition comprising biomass and / or extracts of terrestrial fungi on the one hand and at least a) a layered silicate or an iron-rich raw material or b) fungal biopolymer complexes obtained by alkaline digestion from the cell walls of aphyllophoral basidiomycetes or c) biomasses obtainable from microalgae on the other hand , provided.
- Terrestrial mushrooms have valuable ingredients that are suitable
- Examples of terrestrial mushrooms with as yet insufficiently used ingredients are Auricularia auricula-judae-Judasohr
- Grifola frondosa Maitake Hericium erinaceus - Hedgehog Tortoise Lentinula edodes - Shii-take Pleurotus ostreatus - Oyster Pear Pleurotus eryngii - Herbal Oyster.
- the biomasses or the extracts of terrestrial fungi can be used.
- the biomass of the terrestrial fungi all ingredients are supplied in a physiologically balanced ratio to the recipient organism. It has been found that it is particularly advantageous if the biomass is present in the form of microparticles or nanoparticles with an average diameter of 10 nm-10 ⁇ m.
- the conversion of the biomass into microparticles or nanoparticles can be carried out according to a method known from WO 2004/075907 A2.
- biomass and / or extracts of terrestrial mushrooms are mixed to form biomasses of marine organisms, obtainable from microalgae
- the organism is supplemented, in addition to the ingredients of the selected terrestrial fungi, with proteins, special fatty acids, in particular cell protective omega-3 and omega-6 fatty acids, Minerals and vitamins as well as secondary ingredients supplied in a physiologically engineered ratio.
- proteins special fatty acids, in particular cell protective omega-3 and omega-6 fatty acids, Minerals and vitamins as well as secondary ingredients supplied in a physiologically engineered ratio.
- Both phyllosilicates as fungale Biopolymerkomplexe, biomass from marine organisms as well as commercial mineral mixtures have insufficient radical scavenging properties.
- the preparation of the invention may contain biomass and / or extracts of terrestrial fungi and phyllosilicates, fungal biopolymer complexes and / or biomasses of microalgae and mineral mixtures as two, three or four combinations, and allows good protection against free radicals. In the combinations practically all mixing ratios are possible. This allows various applications that can not be achieved with the individual components.
- the combination according to the invention provides animal and human with high-quality nutrients, ferments, active substances, growth and protective substances in a balanced ratio to fiber and thus strengthens the organism.
- the glucans contained in the combination stimulate the immune system.
- the dietary and probiotic properties of the combination stabilize the natural intestinal flora.
- the composition can be chosen so that a fight against bacterial and viral pathogens by the known contained in G. pfeifferi antimicrobial agents is possible. Free radical damage, responsible for many aging processes of cells and organs, is diminished.
- 1 part of the ethanolic extract of a Ganoderma species is used to 99 parts of the food.
- special effects in terms of the supply of minerals and trace substances can be achieved.
- the combination according to the invention with extracts of terrestrial fungi gives a preparation in which, with regard to the antioxidative properties, an immediate and a depot effect can be detected experimentally.
- Inventive combinations of Ganoderma extracts with zeolites and other ion exchangers cause a synergistic antioxidant effect.
- the microporous structure of the zeolites by their ability to absorb free radicals, promotes anti-oxidant activity. Incorporated substances such as selenium are reinforced in their effect. If the addition according to the invention of alcoholic extracts from a Ganoderma species of a combination of zeolites with important minerals and trace elements is added, both the radical scavenging activity can be improved and the assurance of a balanced balance of macro- and microelements in the organism can be achieved.
- pfeifferi wherein the ethanol content can vary within the limits of 10 vol.% To 96 vol.%. It is also possible to use mixtures of alcohols and ethyl acetate as the extraction agent. It is also possible to use extracts obtained by treating a Ganoderma species with supercritical CO 2 .
- extracts of 5 different Ganoderma species and / or extracts of other terrestrial fungi are mixed.
- lipophilic extracts in particular the alcoholic extract of G. pfeifferi, contain active substances which stimulate the metabolism of healthy cells and reduce cell aging.
- the aqueous extract of G. lucidum contains agents which activate phagocytosis by macrophages and stimulate the immune response.
- the glucan content of the aqueous extract, which stimulates the immune system is lower in G.pfeifferi than in G. lucidum.
- the combination of the ethanolic extract of G. pfeifferi and the aqueous extract of G. lucidum produces the desired effect.
- 2 5 has a relatively low UV adsorption, by additions of biomasses of Ganoderma pfeifferi in the amount of 1 to 10% over the entire wavelength range of 250 to 400 nm comparable to the commercial preparations based on titanium dioxide, z. T. even has superior UV absorption (or reflection). It has proven to be particularly favorable when the biomass from Ganoderma species in the form of micro- and nanoparticles with
- From the group of phyllosilicates can be used for the UV protection in a particularly advantageous manner kaolins, clays, bentonites and other clay mineral-containing rocks.
- Non-clay mineral, but Fe-rich raw materials are used.
- Gaps associated with individual clay mineral groups, such as in kaolins e.g. in the range 280 nm, can be safely avoided by the inventive combination with biomasses from Ganoderma species.
- a clay particle-biomass particle contact network is essential.
- the formation of this network can be influenced, for example, by: pH change
- the process for the preparation of the preparations may be carried out in such a way that the clays dried and / or ground and / or separated and / or otherwise surface-treated, then with a water / oil emulsion, in which either the
- Ratio 1: 10 to 1: 1 are mixed, and both fruiting body and the mycelium can be used for biomass and extract extraction.
- Example 6 Examination of the influence of the locus flora on the mouse ear by preparations according to the invention according to Examples 1, 5 and 6
- Example 8 Influence of grain size in phyllosilicates without permanent charge
- the release was determined by means of paddle apparatus.
- the particle dispersion to be tested is placed directly in the round-bottomed vessel and samples are taken at certain times.
- the particles contained in the measuring solution are filtered off and discarded. You will be deprived of the further release process. To compensate, the sample volume is not replaced, so it can be assumed that the output ratio of particles to dispersion medium remains constant during the course of the experiment.
- the filtrate is analyzed by UV spectrometry for its active ingredient content.
- Membrane filters made of polyamide from Schleicher & Schuell (Dassel, Germany) with a pore size of 0.2 ⁇ m were used for the filtration.
- adherent human cells HaCaT, DKFZ
- adherent human cells HaCaT, DKFZ
- the medium was replaced by 2 ml PBS and the Cells irradiated with a dose of 20mJ / cm 2 UV light (medical UVB, broadband, maximum 311nm).
- the preparation was carried out under standard conditions as shown in the scheme ( Figure 5 extraction scheme for the production of mushroom extracts).
- Ganoderma extracts can significantly reduce UV-induced damage to the keratinocytes.
- FIG. 6 LDH release from HaCaT cells of Ganoderma extracts after irradiation with medical UVB
- Confluent FL cells were treated with mitomycin C to inhibit growth (described in detail in Example 15).
- the cell cultures were fed from the 20th to the 30th h with a commercial medium (Dulbecco's Minimal Essential Medium with 10% calf serum), to which was added 0.025 mg of an ethanolic extract of G. pfeifferi per ml culture medium.
- G. lucidum (not shown) has an opposite effect.
- the cells die here already after 96h.
- Example 15 Detection of the stimulating effect by the preparations according to the invention on stationary cell cultures by determining the protein content of the cells
- Confluent FL cells are treated with mitomycin C to inhibit growth as follows: pour medium from tissue culture flask, wash cell lawn 2 times 5 times with PBS, 5 ml commercial medium (DulbeccoMEM + antibiotics + 10% fetal calf serum + 1% L glutamine) Add 50 ⁇ l mitomycin C (50 ⁇ g) to the cells, incubate for 2h at 37 ° C and 5% CÜ 2 in the incubator, drain the mixture and wash 3 times with PBS. The cells were then trypsinized, in a cell density of 2x10 5 / ml medium in
- the protein determination was carried out with Roti-Nanoquant and a B SA standard as lo calibration solution.
- the protein concentration was determined on the basis of the quotients from the B SA standard curve.
- the G. pfeifferi hot extract used caused a very marked stimulation of the cell metabolism.
- the protein content of the cell increased by 20%.
- 25 ⁇ g / ml have practically no influence, only doubling the concentration to 50 ⁇ g / ml causes an increase in protein production by 5%. In the examination of the finished preparation even a lower protein content was observed.
- FIG. 9 Protein content ( ⁇ g / ml) of cells after cultivation with and without G. pfeifferi in comparison with G. lucidum and ginseng
- HaCaT, DKFZ adherent human cells
- the medium was replaced by 2 ml PBS and the cells irradiated with a dose of 20mJ / cm 2 UV light (medical UVB, broadband, maximum 311nm).
- PBS extracts of Ganoderma species were dissolved at a concentration of 10 ⁇ g / ml (Extr. 1) or 0.01 ⁇ g / ml (Extr. 2).
- the PBS and the extract dissolved therein was removed and replaced with RPMI medium with 0.01% BSA (bovine serum albumin).
- BSA bovine serum albumin
- FIG. 10 LDH release from HaCaT cells after irradiation with medical UVB (broadband)
- the extracts used were able to reduce the damage caused to the cells by UV radiation (FIG. 9).
- the Ganoderma-Extr. 1 (A) gives up to a 5-fold protective effect.
- the less concentrated Ganoderma 5 Extr. 2 ( ⁇ ) an approximately 1.5 fold protective effect for the cells could be detected.
- Titanium dioxide which is very commonly used in sunscreens, enhanced by the photocatalytic effect, the damaging effect of UV rays. Titanium dioxide was used in direct comparison as a suspension of titanium dioxide nanoparticles in PBS with a dose of 3 ⁇ g / cm 2 . (Fig. 10)
- Example 18 Detection of the protective effect of the preparations according to the invention on skin cells in comparison to TiO 2
- the experimental setup was modified in that in the beam path either only a quartz plate (control) or a quartz plate with a corresponding preparation of the invention (clay mineral plus biomass, see Example.10 production) or 20 TiO 2 (in the form a nanoparticle suspension).
- the quartz plate alone does not absorb any UV light in this area.
- the PBS was removed and replaced with RPMI medium containing 8% FCS.
- the morphological development of the cells and the release of the cytoplasmic enzyme lactate dehydrogenase were followed.
- FIG. 11 LDH release from HaCaT cells after irradiation with medical UVB (broadband), preparation from G. pfeifferi and Frieders clay in comparison to TiO 2
- Lactate release is increased under the influence of TiO 2 over the control
- FIG. 7 LDH release from HaCaT cells after irradiation with medical UVB (broadband). Preparation of G.pfeiferi and bentonite Garfield ⁇ 6.3 ⁇ m)
- TiO 2 has an unfavorable effect on skin cells even in this experimental setup in which the photocatalytic effect is not detected.
- Lactate release as a measure of UV-induced damage under the influence of the preparation according to the invention (Example 1 in Fig. 11: Preparation obtainable from G.pfeifferi and Friedlander Ton;
- the UV transmission was measured with the UV photometer Analytik Jena AG SPECORD 50.
- Example 20 Investigation of the compositions according to the invention based on biomass of microalgae of the genus Spirulina enriched with selenium in biologically bound form (selenium spirulina) with and without digestion by heat and pressure
- the determination of the antioxidative properties was carried out by thin-layer chromatography (SIEVERS A et al., (2002) Simple thin-layer chromatography test for antioxidative compounds using DPPH assay, CBS Camag bibliography Service 88: 14-15) and photometrically (MOLYNEUX P (2004).
- Selenium spirulana with a selenium content of 7.5 mg selenium / 100 g has no detectable radical scavenging properties with these test systems.
- the thin-layer chromatographic detection is very sensitive. Concentrations> 0.005% of an antioxidant substance are detectable. By adding 1% G. lucidum extract, an immediately detectable radical scavenging activity of 94% is achieved. An addition of 10% causes a radical scavenging activity of 95.1%.
- Microalgae of the genus Spirulina enriched with zinc in biologically bound form (zinc spirulina)
- Zinc spirulina has a radical scavenging capacity of 20.3%.
- 1% ethanolic extracts of G. lucidum or G. pfeifferi immediately detectable radical scavenging activities of 74, 1, by adding 10% of the extracts 92.3% are achieved.
- Biomass obtainable by cultivating microalgae of the genus Chlamydomonas, has a radical trapping property of 14.8%. By adding 1 30% ethanolic extract of G. lucidum or G. pfeifferi, immediately detectable radical scavenging activities of 77, 3 are achieved by adding 10% of the extracts> 90%.
- Example 20 Biomass, obtainable by culturing microalgae of the genus Porphyridium, have only a low radical scavenging property of 4%. By adding 1% ethanolic extracts of G. lucidum or G. pfeifferi, immediately detectable radical scavenging activities of 40, 7 are achieved by adding 10% of 94%.
- the complex was recovered by alkaline digestion from the cell wall according to Example 29.
- the preparation has the following advantageous application properties: Bioadsorption of heavy metals and toxins, but no adsorption more vital
- Macro- and microelements strengthening the immune system by stimulating the nonspecific defense system and stimulating the anti-inflammatory cytokines
- the complex has no doping with Ganoderma extract on the detectable with the methodology of Example 20 radical scavenging properties (radical scavenging activity 5.3%). This disadvantage is remedied by adding 1% or 10% of an ethanolic extract from G. lucidum. The radical scavenging activity thereby increases to 50 or 93%.
- Example 25 Fungal biopolymer complex obtainable from oyster mushroom substrates (Pleurotus ostreatus)
- the biopolymer complex was recovered by alkaline digestion from the cell walls in analogy to Example 29.
- the investigation of antioxidative properties was carried out according to the method of Example 20.
- the biopolymer complex has a radical scavenging capacity of 5.7%.
- 1% ethanolic extract of G. lucidum By adding 1% ethanolic extract of G. lucidum, immediately detectable radical scavenging activities of 42.2 are achieved, with the addition of 10% of the extracts 89.6%.
- a radical scavenging activity is advantageous, which is achieved by addition of 1 to 10% of an ethanolic extract of G. lucidum (Table 6).
- Example 27 Improvement of radical scavenging properties of fish feed
- % of a Ganoderma extract from 91.4 to 96.4 and 98.9%, respectively.
- 50g dried and ground oyster mushroom (Pilzhof Krummensee) are in a three-necked flask with stirrer, thermometer and reflux condenser with 500 ml dest. Added water and heated to 60 ° C with stirring. Then add 3.5 g of sodium hydroxide (Merck, for analysis) in 50 ml of dist. Dissolved water and heated the mixture for three hours to 90 to
- Ganoderma pfeifferi fruiting bodies were obtained by wild collection in Schlosspark Ludwigsburg in the years 1997-2005. In addition, cultured fruiting bodies, which were obtained by the company GAMU GmbH, Krefeld in April 2004, were used. 2 g of dried mushrooms (Ganoderma pfeifferi) are ground and treated at room temperature with 20 ml of ethanol (Applichem, denatured, for analysis). After 24 hours of cold extraction at room temperature, the fungi are squeezed through a filter and the extract is filtered through a round filter. This gives 12 ml of yellow-colored extract.
- the pulverized fruit body was mixed in a paper tube with ethanol 80% (v / v) and then extracted by the Soxhlet method for about 24 h.
- the weight was 12.5 g for both Ganoderma lucidum and G. pfeifferi.
- the recovered liquid extracts were concentrated and freeze-dried.
- Extraction was carried out using extractor ASE 200 (Dionex, Sunnyvale, CA, USA). In each case, 2 g of powdered mushroom fruit bodies with 15 g of sea sand were weighed into a paper tube. Extraction was carried out at a pressure of 2000 psi (pounds per square inch) with a service life (residence time of the solvent in the extraction cell at each extraction step) of 2 minutes. The extractant used was EtOH 80% (v / v) at an extraction temperature of 60 ° C.
Abstract
Description
Claims
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005031363A DE102005031363A1 (en) | 2005-06-30 | 2005-06-30 | Agent with anti-aging effect, useful to prepare e.g. food supplements or fodder supplements, comprises extract containing effective components and/or a biomass from Ganoderma pipefferi |
DE102005031364A DE102005031364A1 (en) | 2005-06-30 | 2005-06-30 | Free radical scavengers for food supplements, osteoporosis treatment, plant strengtheners, cosmetics and pharmaceuticals contain terrestrial fungus extract, microalgal biomass and fungal biopolymer from Basidomycetes |
DE102005031362A DE102005031362A1 (en) | 2005-06-30 | 2005-06-30 | Composition, useful as sun protecting agent, comprises a silicate layer containing an iron raw material on one side and biomass and/or an extract of terrestrial fungus on the other side |
PCT/EP2006/063773 WO2007003613A2 (en) | 2005-06-30 | 2006-06-30 | Preparations made from natural materials |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1901757A2 true EP1901757A2 (en) | 2008-03-26 |
Family
ID=37487734
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP06792472A Withdrawn EP1901757A2 (en) | 2005-06-30 | 2006-06-30 | Preparations made from natural materials |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1901757A2 (en) |
WO (1) | WO2007003613A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102014200922A1 (en) * | 2014-01-20 | 2015-07-23 | Fim Biotech Gmbh | Use of clay mineral as feed additive and / or as supplementary feed for aquatic organisms |
CN113208987A (en) * | 2020-09-07 | 2021-08-06 | 北京工商大学 | Anti-aging and repairing rice ganoderma lucidum composite fermentation product and preparation method and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3657600A (en) * | 1999-03-09 | 2000-09-28 | Ganomycin Gesellschaft Fur Biomedizinische Forschung MBH | Biologically active compounds of (ganoderma pfeifferi) dms 13239 |
DE102004010690A1 (en) * | 2003-02-27 | 2004-10-21 | Ernst-Moritz-Arndt-Universität Greifswald | Compositions comprising terrestrial mushroom biomass and thiocyanates, e.g. useful as drug carriers, health-promoting products, foods, animal feeds, dietary supplements |
-
2006
- 2006-06-30 WO PCT/EP2006/063773 patent/WO2007003613A2/en active Application Filing
- 2006-06-30 EP EP06792472A patent/EP1901757A2/en not_active Withdrawn
Non-Patent Citations (1)
Title |
---|
See references of WO2007003613A2 * |
Also Published As
Publication number | Publication date |
---|---|
WO2007003613A2 (en) | 2007-01-11 |
WO2007003613A3 (en) | 2007-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101219520B1 (en) | Anti-inflammatory, anti-oxidative or anti-bacterial compositions | |
DE19901270B4 (en) | Process for the liquid cultivation of Schizophyllum commune Fr. for the isolation of β-1,6-branched-β-1,3-glucan | |
JPH1053532A (en) | Antiallergic drug containing plant extract | |
JPH07316035A (en) | Skin external agent | |
DE19944695A1 (en) | Method for strengthening the antitumor activity of a crude drug containing polysaccharides comprises roasting the crude drug by far infrared rays followed by fermentation using microorganisms | |
WO2015022348A1 (en) | Preparation for protection against extrinsic and intrinsic skin aging | |
Giridharan et al. | Studies on green synthesis, characterization and anti-proliferative potential of silver nano particle using Dodonaea viscosa and Capparis decidua | |
JP5192678B2 (en) | Antioxidant plant extract and external preparation, cosmetic, bath preparation and detergent containing the extract | |
JP2013079242A (en) | Antioxidant plant extract, and preparation for external use, cosmetic, bathing agent, and detergent, each containing the extract | |
KR101572067B1 (en) | Honeybee pollen composition | |
DE4320526C2 (en) | Oil preparation and method of making the same | |
JPH10203994A (en) | Physiologically active composition | |
CN106074279A (en) | A kind of anti-ageing facial cream containing Herba Artemisiae montanae Artemisia extract and preparation method thereof | |
WO2007003613A2 (en) | Preparations made from natural materials | |
WO2010012686A1 (en) | Surfactant-free emulsions with anti-aging effect, production thereof and use of same | |
EP2320867A2 (en) | Preparations based on artemisia annua, the conversion thereof into microparticles and nanoparticles, and use of same | |
DE102005031362A1 (en) | Composition, useful as sun protecting agent, comprises a silicate layer containing an iron raw material on one side and biomass and/or an extract of terrestrial fungus on the other side | |
KR101552472B1 (en) | Method for producing Crassostrea gigas extract with increased antioxidant and whitening activity | |
KR101893012B1 (en) | Method for Manufacturing Soap Containing Fermented Medicinal Herbs Include Ginseng | |
JP2001139489A (en) | Cosmetic composition | |
Bhosale et al. | Investigation on Antimicrobial, Antioxidant, and Anti-cancerous activity of Agaricus bisporus derived β-Glucan particles against cervical cancer cell line | |
JP2002053434A (en) | Hair treatment and method for treating hair | |
EP1603409A2 (en) | Salutary compositions consisting of fungi containing lipids and thiocyanates | |
JP2003321379A (en) | Antiallergic agent | |
JP2006213726A (en) | Antiallergic agent containing steviol glycoside |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20080128 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20100914 |
|
R17C | First examination report despatched (corrected) |
Effective date: 20101026 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: PATENTHANDEL PORTFOLIOFONDS I GMBH & CO. KG Owner name: ERNST-MORITZ-ARNDT-UNIVERSITAET GREIFSWALD |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20120807 |